{"id":1262,"date":"2017-02-13T07:27:00","date_gmt":"2017-02-13T07:27:00","guid":{"rendered":"https:\/\/pepharm.gr\/qas-on-shared-facilities-guidance\/"},"modified":"2021-11-29T11:49:52","modified_gmt":"2021-11-29T11:49:52","slug":"qas-on-shared-facilities-guidance","status":"publish","type":"post","link":"https:\/\/pepharm.gr\/en\/qas-on-shared-facilities-guidance\/","title":{"rendered":"Q&#038;As on Shared Facilities Guidance"},"content":{"rendered":"<div dir=\"ltr\" style=\"text-align: left;\">\n<div style=\"text-align: justify;\">\n<div style=\"clear: left; float: left; margin-bottom: 1em; margin-right: 1em; text-align: center;\"><img decoding=\"async\" border=\"0\" height=\"120\" src=\"https:\/\/3.bp.blogspot.com\/-AfFuCAllVnk\/VxYeYSZnFuI\/AAAAAAAAARo\/dwoeVev58Dc2Flnv9y5kSoypSXB8TVK8gCPcB\/s200\/eipg-logo.jpg\" width=\"200\" \/><\/div>\n<p>\u03a4\u03bf \u03c0\u03b1\u03c1\u03b1\u03ba\u03ac\u03c4\u03c9 \u03ad\u03b3\u03b3\u03c1\u03b1\u03c6\u03bf \u03b4\u03b9\u03b1\u03b2\u03bf\u03cd\u03bb\u03b5\u03c5\u03c3\u03b7\u03c2 \u03c4\u03bf\u03c5 \u0395\u039c\u0391 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9  \u03b5\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03c0\u03b1\u03bd\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b5\u03c6\u03b1\u03c1\u03bc\u03bf\u03b3\u03ae \u03c4\u03b7\u03c2 \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7\u03c2 \u03b4\u03b9\u03b1\u03c3\u03c4\u03b1\u03c5\u03c1\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u03bc\u03cc\u03bb\u03c5\u03bd\u03c3\u03b7\u03c2 \u03ba\u03b1\u03c4\u03ac \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03ba\u03b1\u03c4\u03b5\u03c5\u03b8\u03c5\u03bd\u03c4\u03ae\u03c1\u03b9\u03b1 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03b1\u03b8\u03bf\u03c1\u03b9\u03c3\u03bc\u03cc \u03c4\u03c9\u03bd \u03bf\u03c1\u03af\u03c9\u03bd \u03ad\u03ba\u03b8\u03b5\u03c3\u03b7\u03c2 \u03c0\u03bf\u03c5 \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd \u03b1\u03bd\u03b1\u03b3\u03bd\u03ce\u03c1\u03b9\u03c3\u03b7 \u03c4\u03c9\u03bd \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03c9\u03bd \u03c3\u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd \u03c3\u03b5 \u03ba\u03bf\u03b9\u03bd\u03cc\u03c7\u03c1\u03b7\u03c3\u03c4\u03b5\u03c2 \u03b5\u03b3\u03ba\u03b1\u03c4\u03b1\u03c3\u03c4\u03ac\u03c3\u03b5\u03b9\u03c2.<\/p>\n<p><a href=\"https:\/\/goo.gl\/LwZSpU\" target=\"_blank\" rel=\"noopener\">Questions and answers on implementation of risk based prevention of cross contamination in production and &#8220;Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities&#8221; (EMA\/CHMP\/CVMP\/SWP\/169430\/2012)<\/a> <\/div>\n<div style=\"text-align: justify;\"><\/div>\n<div style=\"text-align: justify;\">\u03a0\u03b1\u03c1\u03b1\u03ba\u03b1\u03bb\u03bf\u03cd\u03bc\u03b5 \u03cc\u03c0\u03c9\u03c2 \u03bc\u03b1\u03c2 <a href=\"https:\/\/goo.gl\/forms\/S5KxbOcQD5G7Tz2L2\" target=\"_blank\" rel=\"noopener\">\u03b1\u03c0\u03bf\u03c3\u03c4\u03b5\u03af\u03bb\u03b5\u03c4\u03b5 \u03c4\u03b1 \u03c3\u03c7\u03cc\u03bb\u03b9\u03b1 \u03c3\u03b1\u03c2<\/a> \u03bc\u03ad\u03c7\u03c1\u03b9 \u03c4\u03b7\u03bd 31\u03b7 \u039c\u03b1\u03c1\u03c4\u03af\u03bf\u03c5 2017 \u03c0\u03c1\u03bf\u03ba\u03b5\u03b9\u03bc\u03ad\u03bd\u03bf\u03c5 \u03b7 \u03bf\u03bc\u03ac\u03b4\u03b1 \u03b5\u03c1\u03b3\u03b1\u03c3\u03af\u03b1\u03c2 Regulatory Affairs \u03ba\u03b1\u03b9 \u0392\u03b9\u03bf\u03bc\u03b7\u03c7\u03b1\u03bd\u03b9\u03ba\u03ae\u03c2 \u03a6\u03b1\u03c1\u03bc\u03b1\u03ba\u03b5\u03c5\u03c4\u03b9\u03ba\u03ae\u03c2 \u03c4\u03b7\u03c2 \u03a0\u0395\u03a6 \u03c3\u03b5 \u03c3\u03c5\u03bd\u03b5\u03c1\u03b3\u03b1\u03c3\u03af\u03b1 \u03bc\u03b5 \u03c4\u03bf \u03c4\u03bc\u03ae\u03bc\u03b1  Technical and Professional Development \u03c4\u03b7\u03c2 EIPG \u03bd\u03b1 \u03b1\u03c0\u03bf\u03c3\u03c4\u03b5\u03af\u03bb\u03bf\u03c5\u03bd  \u03c3\u03c5\u03b3\u03ba\u03b5\u03bd\u03c4\u03c1\u03c9\u03c4\u03b9\u03ba\u03ae \u03c6\u03cc\u03c1\u03bc\u03b1 \u03c0\u03c1\u03bf\u03c2 \u03c4\u03bf\u03bd \u0395\u039c\u0391, \u03bc\u03b5 \u03c3\u03c7\u03cc\u03bb\u03b9\u03b1 \u03b3\u03b9\u03b1 \u03c4\u03b7\u03bd \u03c4\u03b5\u03bb\u03b9\u03ba\u03ae \u03b4\u03b9\u03b1\u03bc\u03cc\u03c1\u03c6\u03c9\u03c3\u03b7 \u03c4\u03bf\u03c5  \u03b5\u03b3\u03b3\u03c1\u03ac\u03c6\u03bf\u03c5. <\/div>\n<p><\/div>","protected":false},"excerpt":{"rendered":"<p>\u03a4\u03bf \u03c0\u03b1\u03c1\u03b1\u03ba\u03ac\u03c4\u03c9 \u03ad\u03b3\u03b3\u03c1\u03b1\u03c6\u03bf \u03b4\u03b9\u03b1\u03b2\u03bf\u03cd\u03bb\u03b5\u03c5\u03c3\u03b7\u03c2 \u03c4\u03bf\u03c5 \u0395\u039c\u0391 \u03c0\u03b5\u03c1\u03b9\u03bb\u03b1\u03bc\u03b2\u03ac\u03bd\u03b5\u03b9 \u03b5\u03c1\u03c9\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2 \u03ba\u03b1\u03b9 \u03b1\u03c0\u03b1\u03bd\u03c4\u03ae\u03c3\u03b5\u03b9\u03c2 \u03c3\u03c7\u03b5\u03c4\u03b9\u03ba\u03ac \u03bc\u03b5 \u03c4\u03b7\u03bd \u03b5\u03c6\u03b1\u03c1\u03bc\u03bf\u03b3\u03ae \u03c4\u03b7\u03c2 \u03c0\u03c1\u03cc\u03bb\u03b7\u03c8\u03b7\u03c2 \u03b4\u03b9\u03b1\u03c3\u03c4\u03b1\u03c5\u03c1\u03bf\u03cd\u03bc\u03b5\u03bd\u03b7\u03c2 \u03bc\u03cc\u03bb\u03c5\u03bd\u03c3\u03b7\u03c2 \u03ba\u03b1\u03c4\u03ac \u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae \u03ba\u03b1\u03b9 \u03c4\u03b7\u03bd \u03ba\u03b1\u03c4\u03b5\u03c5\u03b8\u03c5\u03bd\u03c4\u03ae\u03c1\u03b9\u03b1 \u03b3\u03c1\u03b1\u03bc\u03bc\u03ae \u03b3\u03b9\u03b1 \u03c4\u03bf\u03bd \u03ba\u03b1\u03b8\u03bf\u03c1\u03b9\u03c3\u03bc\u03cc \u03c4\u03c9\u03bd \u03bf\u03c1\u03af\u03c9\u03bd \u03ad\u03ba\u03b8\u03b5\u03c3\u03b7\u03c2 \u03c0\u03bf\u03c5 \u03c7\u03c1\u03b7\u03c3\u03b9\u03bc\u03bf\u03c0\u03bf\u03b9\u03bf\u03cd\u03bd\u03c4\u03b1\u03b9 \u03c3\u03c4\u03b7\u03bd \u03b1\u03bd\u03b1\u03b3\u03bd\u03ce\u03c1\u03b9\u03c3\u03b7 \u03c4\u03c9\u03bd \u03ba\u03b9\u03bd\u03b4\u03cd\u03bd\u03c9\u03bd \u03c3\u03c4\u03b7\u03bd \u03c0\u03b1\u03c1\u03b1\u03b3\u03c9\u03b3\u03ae \u03b4\u03b9\u03b1\u03c6\u03bf\u03c1\u03b5\u03c4\u03b9\u03ba\u03ce\u03bd \u03c6\u03b1\u03c1\u03bc\u03ac\u03ba\u03c9\u03bd \u03c3\u03b5 \u03ba\u03bf\u03b9\u03bd\u03cc\u03c7\u03c1\u03b7\u03c3\u03c4\u03b5\u03c2 \u03b5\u03b3\u03ba\u03b1\u03c4\u03b1\u03c3\u03c4\u03ac\u03c3\u03b5\u03b9\u03c2. Questions and answers on implementation of risk based prevention of cross [&hellip;]<\/p>","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"pmpro_default_level":"","footnotes":""},"categories":[54,168],"tags":[],"class_list":["post-1262","post","type-post","status-publish","format-standard","hentry","category-54","category-168","pmpro-has-access"],"acf":[],"_links":{"self":[{"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/posts\/1262","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/comments?post=1262"}],"version-history":[{"count":1,"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/posts\/1262\/revisions"}],"predecessor-version":[{"id":2092,"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/posts\/1262\/revisions\/2092"}],"wp:attachment":[{"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/media?parent=1262"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/categories?post=1262"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pepharm.gr\/en\/wp-json\/wp\/v2\/tags?post=1262"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}